JP2015518876A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015518876A5 JP2015518876A5 JP2015515606A JP2015515606A JP2015518876A5 JP 2015518876 A5 JP2015518876 A5 JP 2015518876A5 JP 2015515606 A JP2015515606 A JP 2015515606A JP 2015515606 A JP2015515606 A JP 2015515606A JP 2015518876 A5 JP2015518876 A5 JP 2015518876A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- methylimidazo
- diazaspiro
- nonan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261655177P | 2012-06-04 | 2012-06-04 | |
| US61/655,177 | 2012-06-04 | ||
| US201361812416P | 2013-04-16 | 2013-04-16 | |
| US61/812,416 | 2013-04-16 | ||
| PCT/IB2013/054177 WO2013182933A1 (en) | 2012-06-04 | 2013-05-21 | Use of ghrelin receptor inverse agonists or antagonists for treating sleep disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015518876A JP2015518876A (ja) | 2015-07-06 |
| JP2015518876A5 true JP2015518876A5 (enExample) | 2016-07-07 |
| JP6165852B2 JP6165852B2 (ja) | 2017-07-19 |
Family
ID=48700662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015515606A Expired - Fee Related JP6165852B2 (ja) | 2012-06-04 | 2013-05-21 | 睡眠障害を治療するためのグレリン受容体逆アゴニストまたはアンタゴニストの使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9370516B2 (enExample) |
| EP (1) | EP2854856B1 (enExample) |
| JP (1) | JP6165852B2 (enExample) |
| KR (1) | KR101708989B1 (enExample) |
| CN (1) | CN104334193A (enExample) |
| AU (1) | AU2013273263B2 (enExample) |
| BR (1) | BR112014029577A2 (enExample) |
| CA (1) | CA2874196C (enExample) |
| ES (1) | ES2716303T3 (enExample) |
| HK (1) | HK1202459A1 (enExample) |
| IL (1) | IL235883A0 (enExample) |
| MX (1) | MX2014014813A (enExample) |
| RU (1) | RU2600895C2 (enExample) |
| SG (1) | SG11201407387UA (enExample) |
| WO (1) | WO2013182933A1 (enExample) |
| ZA (1) | ZA201408672B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105175272A (zh) * | 2015-08-31 | 2015-12-23 | 吴玲 | 制备r-5-溴-1-氨基茚满的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| US6414002B1 (en) | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| CA2508995A1 (en) * | 2002-12-20 | 2004-07-15 | The Mclean Hospital Corporation | Use of cytidine-, creatine-, and adenosine-containing compounds and adenosine-elevating compounds for normalizing sleep/wake cycle, treating a sleep disorder or improving cognitive function |
| US20050171132A1 (en) * | 2003-09-26 | 2005-08-04 | Zhili Xin | Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists |
| US20090149512A1 (en) * | 2004-05-14 | 2009-06-11 | Novo Nordisk A/S | Use of Ghrelin Antagonists to the Treatment of Certain CNS Diseases |
| AU2007273057A1 (en) * | 2006-07-12 | 2008-01-17 | Merck Sharp & Dohme Corp. | Substituted pyrazoles as ghrelin receptor antagonists |
| US8309530B2 (en) * | 2009-02-04 | 2012-11-13 | Washington State University | Compositions and methods for modulating ghrelin-mediated conditions |
| PL2547679T3 (pl) * | 2010-03-19 | 2016-02-29 | Pfizer | Pochodne 2,3-dihydro-1H-inden-1-ylo-2,7-diazaspiro[3.5]nonanu i ich zastosowanie jako antagonistów lub odwrotnych agonistów receptora greliny |
-
2013
- 2013-05-21 ES ES13732257T patent/ES2716303T3/es active Active
- 2013-05-21 HK HK15103243.2A patent/HK1202459A1/xx unknown
- 2013-05-21 WO PCT/IB2013/054177 patent/WO2013182933A1/en not_active Ceased
- 2013-05-21 AU AU2013273263A patent/AU2013273263B2/en not_active Ceased
- 2013-05-21 KR KR1020147034009A patent/KR101708989B1/ko not_active Expired - Fee Related
- 2013-05-21 CA CA2874196A patent/CA2874196C/en not_active Expired - Fee Related
- 2013-05-21 RU RU2014146109/15A patent/RU2600895C2/ru not_active IP Right Cessation
- 2013-05-21 US US14/398,800 patent/US9370516B2/en active Active
- 2013-05-21 BR BR112014029577A patent/BR112014029577A2/pt active Search and Examination
- 2013-05-21 EP EP13732257.4A patent/EP2854856B1/en not_active Not-in-force
- 2013-05-21 CN CN201380029429.7A patent/CN104334193A/zh active Pending
- 2013-05-21 JP JP2015515606A patent/JP6165852B2/ja not_active Expired - Fee Related
- 2013-05-21 MX MX2014014813A patent/MX2014014813A/es unknown
- 2013-05-21 SG SG11201407387UA patent/SG11201407387UA/en unknown
-
2014
- 2014-11-24 IL IL235883A patent/IL235883A0/en unknown
- 2014-11-25 ZA ZA2014/08672A patent/ZA201408672B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20220766T1 (hr) | Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora | |
| IL266894B (en) | Preparation of (s)-4-(8-amino-3-(1-but-2-ynoyl-pyrrolidin-2-yl)imidazo[5,1-a]pyrazin-1-yl)-n-(pyridine- 2-l) Benzamide and its acceptable pharmaceutical salts | |
| MX377802B (es) | Metodos y composiciones para trastornos del sueño y otros trastornos. | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| CA2918938C (en) | Substituted aminopyrimidine compounds and methods of use | |
| PH12015502628B1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| JP2010529118A5 (enExample) | ||
| CL2015000578A1 (es) | Compuesto n-(2-(6-fluoro-1-h-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoxi)bencilamina o su sal, antagonista del receptor 5-ht6; composicion farmaceutica; uso en el tratamiento de la enfermedad de alzheimer. | |
| WO2013170068A3 (en) | Nuclear transport modulators and uses thereof | |
| HRP20151399T1 (hr) | Kinazni inhibitor koji regulira signalni put apoptoze | |
| CL2013003051A1 (es) | Compuestos derivados de pirazolo (4.3-d) pirimidinas, inhibidores de quinasa; composicion farmaceutica; y uso para el tratamiento de enfermedades y trastornos del aparato respiratorio | |
| JP2013525444A5 (enExample) | ||
| HRP20250250T1 (hr) | Derivati 7‑benzil‑4‑(2‑metilbenzil)‑2,4,6,7,8,9‑heksahidroimidazo[1,2‑a]pirido[3,4‑e] pirimidin‑5(1h)‑ona, njihove soli i njihova upotreba u terapiji | |
| MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
| MX2016006564A (es) | Compuestos dihidropirimidina y su aplicacion en productos farmaceuticos. | |
| GEP20257716B (en) | Condensed imidazole derivatives substituted by tertiary hydroxy groups as pi3k-gamma inhibitors | |
| RU2017105353A (ru) | Соединения | |
| HRP20120918T1 (hr) | Aminopirazolski spoj | |
| CL2015002606A1 (es) | Compuesto. | |
| HRP20171824T1 (hr) | (TIENO[2,3-b][1,5]BENZOKSAZEPIN-4-IL)PIPERAZIN-1-ILNI SPOJEVI S DVOJNOM AKTIVNOŠĆU INVERZNIH AGONISTA H1 I ANTAGONISTA 5-HT2A | |
| JP2015500223A5 (enExample) | ||
| PE20191241A1 (es) | Formas de administracion farmaceutica que contienen inhibidores de canales task-1 y task-3 y su uso para el tratamiento de trastornos respiratorios | |
| WO2015085909A8 (zh) | 一种具有腺苷受体拮抗活性的氨基嘧啶杂环化合物 | |
| EA201592254A1 (ru) | Производные пиразолопирролидин-4-она и их применение при лечении заболевания |